USADA announced today that Kahmari Montgomery, of Houston, Texas, an athlete in the sport of track and field, has accepted a one-month suspension—the minimum allowed under the applicable rules—for an anti-doping rule violation.
Montgomery, 23, tested positive for 11-nor-9-carboxy-tetrahydrocannabinol (Carboxy-THC), a urinary metabolite of Δ9-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, marijuana, and/or hashish, above the urinary Decision Limit of 180 ng/mL, as the result of a sample collected in competition at the Miramar Invitational on April 10, 2021. Cannabis, marijuana, and hashish are Specified Substances in the class of Cannabinoids and are prohibited in competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the World Athletics Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
The 2021 World Anti-Doping Code newly classifies THC as a “Substance of Abuse” because it is used outside the context of sport. If an athlete who tests positive for a Substance of Abuse establishes that their use of the substance occurred out of competition and was unrelated to sport performance, the athlete will receive a three-month sanction. If the athlete satisfactorily completes a Substance of Abuse treatment program approved by USADA, the sanction may be further reduced to one month.
In this case, Montgomery accepted a one-month period of ineligibility that began on April 30, 2021, the date his provisional suspension was imposed. Montgomery’s period of ineligibility was reduced to one month because his use of cannabis occurred out of competition and was unrelated to sport performance, and because he successfully completed a counseling program regarding his use of cannabis. Montgomery’s competitive results obtained on and subsequent to April 10, 2021, the date his positive sample was collected, have been disqualified, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at email@example.com, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.